ANNALS OF THE RHEUMATIC DISEASES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=489561, encodeId=10bf4895615f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我投了两篇，第一篇1个月后被拒掉了，但3个reviewer中一个肯定，一个中立，反对的那个根本没仔细看文章。。问的问题都不对，所以正准备申诉中。 第二篇投了半个多月了，目前正在peer review。 师兄的一篇没送审就被拒，说不符合杂志的scope。 总之我感觉这个杂志没有AR难，而且审稿周期超快，一般一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=483, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=aquabelle, createdTime=Tue Jul 10 16:33:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489522, encodeId=aa2348952284, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：极难中的哦，风湿领域顶级杂志，哪这么容易呀。拒稿理由包括：我们版面有限呀，你的文章不太合适我们呀等等，这都只是理由而已, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=RA2012, createdTime=Mon Jul 09 11:18:00 CST 2012, time=2012-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489502, encodeId=d58a489502fc, content=请问，一般它拒稿的理由都是什么？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435064061, createdName=crystalyang, createdTime=Sat Jul 07 17:09:00 CST 2012, time=2012-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489129, encodeId=1cf548912945, content=刚投了一篇我抱着调戏它的心态结果肯定我也被它调戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 15:40:00 CST 2012, time=2012-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484237, encodeId=324248423e82, content=几分钟以前刚投了一篇。稿号是20多万了。不知道是不是今年排的，悲摧的命运可能性大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 02 16:11:00 CST 2011, time=2011-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472976, encodeId=20c04e29763c, content=请问风湿病领域排行老大的是哪个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 15 16:33:00 CST 2010, time=2010-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469318, encodeId=611c46931839, content=风湿病领域排行老二的《Annals of the Rheumatic Diseases》，其Acceptance rate 为29%，也就是说拒稿率为71%，但事实上确是很难中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 01 19:51:00 CST 2009, time=2009-10-01, status=1, ipAttribution=)]

2012-07-10 aquabelle

审稿速度:1.0 | 投稿命中率:25.0
经验分享：我投了两篇，第一篇1个月后被拒掉了，但3个reviewer中一个肯定，一个中立，反对的那个根本没仔细看文章。。问的问题都不对，所以正准备申诉中。

第二篇投了半个多月了，目前正在peer review。

师兄的一篇没送审就被拒，说不符合杂志的scope。

总之我感觉这个杂志没有AR难，而且审稿周期超快，一般一个月。

483 0

[GetPortalCommentsPageByObjectIdResponse(id=489561, encodeId=10bf4895615f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我投了两篇，第一篇1个月后被拒掉了，但3个reviewer中一个肯定，一个中立，反对的那个根本没仔细看文章。。问的问题都不对，所以正准备申诉中。 第二篇投了半个多月了，目前正在peer review。 师兄的一篇没送审就被拒，说不符合杂志的scope。 总之我感觉这个杂志没有AR难，而且审稿周期超快，一般一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=483, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=aquabelle, createdTime=Tue Jul 10 16:33:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489522, encodeId=aa2348952284, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：极难中的哦，风湿领域顶级杂志，哪这么容易呀。拒稿理由包括：我们版面有限呀，你的文章不太合适我们呀等等，这都只是理由而已, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=RA2012, createdTime=Mon Jul 09 11:18:00 CST 2012, time=2012-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489502, encodeId=d58a489502fc, content=请问，一般它拒稿的理由都是什么？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435064061, createdName=crystalyang, createdTime=Sat Jul 07 17:09:00 CST 2012, time=2012-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489129, encodeId=1cf548912945, content=刚投了一篇我抱着调戏它的心态结果肯定我也被它调戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 15:40:00 CST 2012, time=2012-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484237, encodeId=324248423e82, content=几分钟以前刚投了一篇。稿号是20多万了。不知道是不是今年排的，悲摧的命运可能性大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 02 16:11:00 CST 2011, time=2011-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472976, encodeId=20c04e29763c, content=请问风湿病领域排行老大的是哪个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 15 16:33:00 CST 2010, time=2010-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469318, encodeId=611c46931839, content=风湿病领域排行老二的《Annals of the Rheumatic Diseases》，其Acceptance rate 为29%，也就是说拒稿率为71%，但事实上确是很难中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 01 19:51:00 CST 2009, time=2009-10-01, status=1, ipAttribution=)]

2012-07-09 RA2012

审稿速度:3.0 | 投稿命中率:25.0
经验分享：极难中的哦，风湿领域顶级杂志，哪这么容易呀。拒稿理由包括：我们版面有限呀，你的文章不太合适我们呀等等，这都只是理由而已

409 0

[GetPortalCommentsPageByObjectIdResponse(id=489561, encodeId=10bf4895615f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我投了两篇，第一篇1个月后被拒掉了，但3个reviewer中一个肯定，一个中立，反对的那个根本没仔细看文章。。问的问题都不对，所以正准备申诉中。 第二篇投了半个多月了，目前正在peer review。 师兄的一篇没送审就被拒，说不符合杂志的scope。 总之我感觉这个杂志没有AR难，而且审稿周期超快，一般一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=483, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=aquabelle, createdTime=Tue Jul 10 16:33:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489522, encodeId=aa2348952284, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：极难中的哦，风湿领域顶级杂志，哪这么容易呀。拒稿理由包括：我们版面有限呀，你的文章不太合适我们呀等等，这都只是理由而已, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=RA2012, createdTime=Mon Jul 09 11:18:00 CST 2012, time=2012-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489502, encodeId=d58a489502fc, content=请问，一般它拒稿的理由都是什么？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435064061, createdName=crystalyang, createdTime=Sat Jul 07 17:09:00 CST 2012, time=2012-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489129, encodeId=1cf548912945, content=刚投了一篇我抱着调戏它的心态结果肯定我也被它调戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 15:40:00 CST 2012, time=2012-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484237, encodeId=324248423e82, content=几分钟以前刚投了一篇。稿号是20多万了。不知道是不是今年排的，悲摧的命运可能性大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 02 16:11:00 CST 2011, time=2011-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472976, encodeId=20c04e29763c, content=请问风湿病领域排行老大的是哪个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 15 16:33:00 CST 2010, time=2010-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469318, encodeId=611c46931839, content=风湿病领域排行老二的《Annals of the Rheumatic Diseases》，其Acceptance rate 为29%，也就是说拒稿率为71%，但事实上确是很难中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 01 19:51:00 CST 2009, time=2009-10-01, status=1, ipAttribution=)]

2012-07-07 crystalyang

请问，一般它拒稿的理由都是什么？谢谢

360 0

[GetPortalCommentsPageByObjectIdResponse(id=489561, encodeId=10bf4895615f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我投了两篇，第一篇1个月后被拒掉了，但3个reviewer中一个肯定，一个中立，反对的那个根本没仔细看文章。。问的问题都不对，所以正准备申诉中。 第二篇投了半个多月了，目前正在peer review。 师兄的一篇没送审就被拒，说不符合杂志的scope。 总之我感觉这个杂志没有AR难，而且审稿周期超快，一般一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=483, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=aquabelle, createdTime=Tue Jul 10 16:33:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489522, encodeId=aa2348952284, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：极难中的哦，风湿领域顶级杂志，哪这么容易呀。拒稿理由包括：我们版面有限呀，你的文章不太合适我们呀等等，这都只是理由而已, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=RA2012, createdTime=Mon Jul 09 11:18:00 CST 2012, time=2012-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489502, encodeId=d58a489502fc, content=请问，一般它拒稿的理由都是什么？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435064061, createdName=crystalyang, createdTime=Sat Jul 07 17:09:00 CST 2012, time=2012-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489129, encodeId=1cf548912945, content=刚投了一篇我抱着调戏它的心态结果肯定我也被它调戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 15:40:00 CST 2012, time=2012-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484237, encodeId=324248423e82, content=几分钟以前刚投了一篇。稿号是20多万了。不知道是不是今年排的，悲摧的命运可能性大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 02 16:11:00 CST 2011, time=2011-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472976, encodeId=20c04e29763c, content=请问风湿病领域排行老大的是哪个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 15 16:33:00 CST 2010, time=2010-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469318, encodeId=611c46931839, content=风湿病领域排行老二的《Annals of the Rheumatic Diseases》，其Acceptance rate 为29%，也就是说拒稿率为71%，但事实上确是很难中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 01 19:51:00 CST 2009, time=2009-10-01, status=1, ipAttribution=)]

2012-06-26 匿名用户

刚投了一篇我抱着调戏它的心态结果肯定我也被它调戏了

397 0

[GetPortalCommentsPageByObjectIdResponse(id=489561, encodeId=10bf4895615f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我投了两篇，第一篇1个月后被拒掉了，但3个reviewer中一个肯定，一个中立，反对的那个根本没仔细看文章。。问的问题都不对，所以正准备申诉中。 第二篇投了半个多月了，目前正在peer review。 师兄的一篇没送审就被拒，说不符合杂志的scope。 总之我感觉这个杂志没有AR难，而且审稿周期超快，一般一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=483, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=aquabelle, createdTime=Tue Jul 10 16:33:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489522, encodeId=aa2348952284, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：极难中的哦，风湿领域顶级杂志，哪这么容易呀。拒稿理由包括：我们版面有限呀，你的文章不太合适我们呀等等，这都只是理由而已, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=RA2012, createdTime=Mon Jul 09 11:18:00 CST 2012, time=2012-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489502, encodeId=d58a489502fc, content=请问，一般它拒稿的理由都是什么？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435064061, createdName=crystalyang, createdTime=Sat Jul 07 17:09:00 CST 2012, time=2012-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489129, encodeId=1cf548912945, content=刚投了一篇我抱着调戏它的心态结果肯定我也被它调戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 15:40:00 CST 2012, time=2012-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484237, encodeId=324248423e82, content=几分钟以前刚投了一篇。稿号是20多万了。不知道是不是今年排的，悲摧的命运可能性大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 02 16:11:00 CST 2011, time=2011-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472976, encodeId=20c04e29763c, content=请问风湿病领域排行老大的是哪个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 15 16:33:00 CST 2010, time=2010-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469318, encodeId=611c46931839, content=风湿病领域排行老二的《Annals of the Rheumatic Diseases》，其Acceptance rate 为29%，也就是说拒稿率为71%，但事实上确是很难中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 01 19:51:00 CST 2009, time=2009-10-01, status=1, ipAttribution=)]

2011-09-02 匿名用户

几分钟以前刚投了一篇。稿号是20多万了。不知道是不是今年排的，悲摧的命运可能性大。

375 0

[GetPortalCommentsPageByObjectIdResponse(id=489561, encodeId=10bf4895615f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我投了两篇，第一篇1个月后被拒掉了，但3个reviewer中一个肯定，一个中立，反对的那个根本没仔细看文章。。问的问题都不对，所以正准备申诉中。 第二篇投了半个多月了，目前正在peer review。 师兄的一篇没送审就被拒，说不符合杂志的scope。 总之我感觉这个杂志没有AR难，而且审稿周期超快，一般一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=483, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=aquabelle, createdTime=Tue Jul 10 16:33:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489522, encodeId=aa2348952284, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：极难中的哦，风湿领域顶级杂志，哪这么容易呀。拒稿理由包括：我们版面有限呀，你的文章不太合适我们呀等等，这都只是理由而已, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=RA2012, createdTime=Mon Jul 09 11:18:00 CST 2012, time=2012-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489502, encodeId=d58a489502fc, content=请问，一般它拒稿的理由都是什么？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435064061, createdName=crystalyang, createdTime=Sat Jul 07 17:09:00 CST 2012, time=2012-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489129, encodeId=1cf548912945, content=刚投了一篇我抱着调戏它的心态结果肯定我也被它调戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 15:40:00 CST 2012, time=2012-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484237, encodeId=324248423e82, content=几分钟以前刚投了一篇。稿号是20多万了。不知道是不是今年排的，悲摧的命运可能性大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 02 16:11:00 CST 2011, time=2011-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472976, encodeId=20c04e29763c, content=请问风湿病领域排行老大的是哪个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 15 16:33:00 CST 2010, time=2010-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469318, encodeId=611c46931839, content=风湿病领域排行老二的《Annals of the Rheumatic Diseases》，其Acceptance rate 为29%，也就是说拒稿率为71%，但事实上确是很难中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 01 19:51:00 CST 2009, time=2009-10-01, status=1, ipAttribution=)]

2010-12-15 匿名用户

请问风湿病领域排行老大的是哪个?

387 0

[GetPortalCommentsPageByObjectIdResponse(id=489561, encodeId=10bf4895615f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：我投了两篇，第一篇1个月后被拒掉了，但3个reviewer中一个肯定，一个中立，反对的那个根本没仔细看文章。。问的问题都不对，所以正准备申诉中。 第二篇投了半个多月了，目前正在peer review。 师兄的一篇没送审就被拒，说不符合杂志的scope。 总之我感觉这个杂志没有AR难，而且审稿周期超快，一般一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=483, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=aquabelle, createdTime=Tue Jul 10 16:33:00 CST 2012, time=2012-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489522, encodeId=aa2348952284, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：极难中的哦，风湿领域顶级杂志，哪这么容易呀。拒稿理由包括：我们版面有限呀，你的文章不太合适我们呀等等，这都只是理由而已, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=RA2012, createdTime=Mon Jul 09 11:18:00 CST 2012, time=2012-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489502, encodeId=d58a489502fc, content=请问，一般它拒稿的理由都是什么？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435064061, createdName=crystalyang, createdTime=Sat Jul 07 17:09:00 CST 2012, time=2012-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489129, encodeId=1cf548912945, content=刚投了一篇我抱着调戏它的心态结果肯定我也被它调戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 26 15:40:00 CST 2012, time=2012-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484237, encodeId=324248423e82, content=几分钟以前刚投了一篇。稿号是20多万了。不知道是不是今年排的，悲摧的命运可能性大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 02 16:11:00 CST 2011, time=2011-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472976, encodeId=20c04e29763c, content=请问风湿病领域排行老大的是哪个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 15 16:33:00 CST 2010, time=2010-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469318, encodeId=611c46931839, content=风湿病领域排行老二的《Annals of the Rheumatic Diseases》，其Acceptance rate 为29%，也就是说拒稿率为71%，但事实上确是很难中的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 01 19:51:00 CST 2009, time=2009-10-01, status=1, ipAttribution=)]

2009-10-01 匿名用户

风湿病领域排行老二的《Annals of the Rheumatic Diseases》，其Acceptance rate 为29%，也就是说拒稿率为71%，但事实上确是很难中的

573 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务